Analysts following hVIVO PLC have made some modest upgrades to earnings forecasts in the wake of the contract research group’s better-than-expected prelims.
Number crunchers at Liberum have increased their 2023 EBITDA number by 4% to £9.4mln, while their counterparts at finnCap have tweaked up the number by £600,000 to £9mln, while forecast profit before tax forecast rises £300,000 to £5.6mln.
finnCap kept its price target unchanged at 35p, while Liberum has increased its valuation by 1.2p to 26.3p.
In afternoon trade, hVIVO stock was changing hands for 17p, valuing the business at £115mln.